bluebird bio (BLUE) stock forecast for 2026
Last update: 05-22-2022, 12:16
Sector: HealthcareThe share price of bluebird bio, Inc. (BLUE) now
What analysts predict:: $7.44
52-week high/low: $23.04 / $3.08
50/200 Day Moving Average: $4.315 / $8.93
This figure corresponds to the average price over the previous 50/200 days. For bluebird bio stocks, the 50-day moving average is the resistance level today.
For bluebird bio stocks, the 200-day moving average is the resistance level today.
Are you interested in bluebird bio stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the bluebird bio stock price in 2026. How much will one bluebird bio share be worth in 2026?
Is it worth taking profit / loss on bluebird bio stock now or waiting? What are analysts' forecasts for bluebird bio stock?
We forecast bluebird bio stock performance using neural networks based on historical data on bluebird bio stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
The bluebird bio stock prediction results are shown below and presented as a graph, table and text information.
bluebird bio stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for bluebird bio analysts is $7.44.
Today 200 Day Moving Average is the resistance level (8.93 $).
50 Day Moving Average is the resistance level (4.315 $).
Historical and forecast chart of bluebird bio stock
The chart below shows the historical price of bluebird bio stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the bluebird bio stock price can be found in the table below.
bluebird bio (BLUE) Forecast for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 6.12 | 5.39 | 6.78 | 20.45 % |
| Feb | 5.72 | 4.90 | 6.35 | 22.79 % |
| Mar | 6.43 | 5.77 | 6.84 | 15.72 % |
| Apr | 6.83 | 6.47 | 7.18 | 9.84 % |
| May | 7.15 | 6.20 | 7.77 | 20.22 % |
| Jun | 6.67 | 5.56 | 7.35 | 24.37 % |
| Jul | 7.10 | 5.96 | 7.61 | 21.74 % |
| Aug | 8.41 | 7.60 | 9.71 | 21.73 % |
| Sep | 7.10 | 5.85 | 7.66 | 23.65 % |
| Oct | 7.72 | 6.48 | 8.91 | 27.26 % |
| Nov | 7.60 | 6.27 | 8.82 | 29.00 % |
| Dec | 6.83 | 6.49 | 8.04 | 19.27 % |
bluebird bio information and performance
Bluebird Bio, Inc. provides biotech products and services: gene therapy for serious genetic disorders such as infantile cerebral adrenoleukodystrophy, neurodegenerative disorders and beta thalassemia. The company operates in the United States.
bluebird bio Address
60 BINNEY STREET, CAMBRIDGE, MA, US
Market Capitalization: 239 370 000 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA: -664 955 008 $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio: None
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio: 0.32
Price/earnings to growth
DPS: N/A
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
DY: N/A
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS: -10.43
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: 1.176
Trailing PE: -
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE: -
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue: 29.0
Enterprise Value (EV) /Revenue
EV To EBITDA: 0.193
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding: 71454000
Number of issued ordinary shares
Shares Float: N/A
Number of freely tradable shares
Shares Short Prior Month: N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A
bluebird bio price target for 2021 by month
Target values for the price of one bluebird bio share for Jan 2026.
Pessimistic target level: 5.39
Optimistic target level: 6.78
Target values for the price of one bluebird bio share for Feb 2026.
Pessimistic target level: 4.90
Optimistic target level: 6.35
Target values for the price of one bluebird bio share for Mar 2026.
Pessimistic target level: 5.77
Optimistic target level: 6.84
Target values for the price of one bluebird bio share for Apr 2026.
Pessimistic target level: 6.47
Optimistic target level: 7.18
Target values for the price of one bluebird bio share for May 2026.
Pessimistic target level: 6.20
Optimistic target level: 7.77
Target values for the price of one bluebird bio share for Jun 2026.
Pessimistic target level: 5.56
Optimistic target level: 7.35
Target values for the price of one bluebird bio share for Jul 2026.
Pessimistic target level: 5.96
Optimistic target level: 7.61
Target values for the price of one bluebird bio share for Aug 2026.
Pessimistic target level: 7.60
Optimistic target level: 9.71
Target values for the price of one bluebird bio share for Sep 2026.
Pessimistic target level: 5.85
Optimistic target level: 7.66
Target values for the price of one bluebird bio share for Oct 2026.
Pessimistic target level: 6.48
Optimistic target level: 8.91
Target values for the price of one bluebird bio share for Nov 2026.
Pessimistic target level: 6.27
Optimistic target level: 8.82
Target values for the price of one bluebird bio share for Dec 2026.
Pessimistic target level: 6.49
Optimistic target level: 8.04